FDA Fast Tracked ADI-001: Adicet Bio Progresses Clinical Trial for Systemic Sclerosis

Adicet Bio has recently taken a significant step forward in the development of a potential new treatment for several challenging autoimmune diseases. On July 25, 2025, the company announced it had dosed the first participant with Systemic Sclerosis